In a filing, CVS Health Corp revealed its Director SANSONE GUY P acquired Company’s shares for reported $0.1 million on Jun 05 ’25. In the deal valued at $63.70 per share,1,570 shares were bought. As a result of this transaction, SANSONE GUY P now holds 12,007 shares worth roughly $0.8 million.
Then, ROBBINS LARRY sold 2,276,068 shares, generating $154,444,758 in total proceeds. Upon selling the shares at $67.86, the Director now owns 9,670,731 shares.
Before that, ROBBINS LARRY sold 1,323,932 shares. CVS Health Corp shares valued at $89,249,945 were divested by the Director at a price of $67.41 per share. As a result of the transaction, ROBBINS LARRY now holds 8,346,799 shares, worth roughly $557.65 million.
Leerink Partners upgraded its CVS Health Corp [CVS] rating to an Outperform from a a Market perform in a research note published on February 13, 2025; the price target was increased to $75 from $55. A number of analysts have revised their coverage, including Cantor Fitzgerald’s analysts, who increased its forecast for the stock in mid February from “a Neutral” to “an Overweight”. Edward Jones also remained covering CVS and has increased its forecast on January 30, 2025 with a “Buy” recommendation from previously “Hold” rating. Deutsche Bank revised its rating on December 03, 2024. It rated CVS as “a Buy” which previously was an “a Hold”.
Price Performance Review of CVS
On Monday, CVS Health Corp [NYSE:CVS] saw its stock jump 0.36%% to $66.81. Over the last five days, the stock has lost -0.96%. CVS Health Corp shares have risen nearly 9.51% since the year began. Nevertheless, the stocks have risen 48.83% over the past one year. While a 52-week high of $72.51 was reached on 05/01/25, a 52-week low of $43.56 was recorded on 01/02/25.
Levels Of Support And Resistance For CVS Stock
The 24-hour chart illustrates a support level at 66.08, which if violated will result in even more drops to 65.35. On the upside, there is a resistance level at 67.33. A further resistance level may holdings at 67.85.
